Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02187770 · ClinicalTrials.gov registry record
Precision of IMED-4 Lung Fluid Measurements
A clinical trial of Dyspnea and Pulmonary Congestion, sponsored by Intersection Medical.
- Completed
- Registry status
- 46
- Enrollment target
- 3
- Study locations
NCT02187770: Completed study of Dyspnea and Pulmonary Congestion, sponsored by Intersection Medical.
NCT02187770 is a study of Dyspnea and Pulmonary Congestion that has completed, run by Intersection Medical. The registered enrollment target is 46 participants, below the 304-participant average among 23 other Dyspnea trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02187770, a study of Dyspnea and Pulmonary Congestion, has completed, sponsored by Intersection Medical.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to determine if IMED-4 recordings have sufficient precision to detect a clinically significant change in lung fluid status in acute heart failure syndrome with pulmonary congestion.
Primary Outcome
IMED 4 is a new device to measure lung fluid status by assessing how wet or dry the lungs are
Conditions Studied
Interventions
- DEVICE IMED-4
Study Locations (3)
Massachusetts
- Mass General Hospital - Boston
Michigan
- Henry Ford Hospital - Detroit
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-10 |
What the finished NCT02187770 record still lists
NCT02187770 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 304-participant average among 23 other Dyspnea trials with a reported enrollment target (85% lower).
The record links to 3 conditions, with Dyspnea appearing as the primary indexed condition, and to 1 intervention - of which IMED-4 is the first listed.
NCT02187770 reports a single indexed study location in Massachusetts, Michigan, Ohio.
Frequently Asked Questions
What is clinical trial NCT02187770 about?
NCT02187770 is a clinical study titled "Precision of IMED-4 Lung Fluid Measurements". The purpose of this study is to determine if IMED-4 recordings have sufficient precision to detect a clinically significant change in lung fluid status in acute heart failure syndrome with pulmonary congestion.
What is the current status of trial NCT02187770?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2014-07. Estimated completion is 2015-10.
What conditions does trial NCT02187770 study?
This clinical trial studies the following conditions: Dyspnea, Pulmonary Congestion, Acute Heart Failure Syndrome.
What interventions are being tested in trial NCT02187770?
The interventions under investigation include: IMED-4 (DEVICE).
Who is sponsoring clinical trial NCT02187770?
This trial is sponsored by Intersection Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02187770 being conducted?
This trial has 3 study locations across Massachusetts, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02187770's enrollment target sits among peer trials
46 15th of 23 higher than 9 of 23 other Dyspnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dyspnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
RECRUITING · Phase 2
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
RECRUITING
-
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
RECRUITING · Phase 2
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia